Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
09 2020
Historique:
received: 14 05 2020
revised: 30 06 2020
accepted: 01 07 2020
pubmed: 18 7 2020
medline: 26 8 2020
entrez: 18 7 2020
Statut: ppublish

Résumé

To assess the prevalence, characteristics and prognostic value of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in hospitalised, non-intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). This single-centre, observational, cross-sectional study included 211 patients with COVID-19 admitted to non-ICU departments who underwent a single transthoracic echocardiography (TTE). Patients with poor acoustic window (n=11) were excluded. Clinical, imaging, laboratory and TTE findings were compared in patients with versus without PH (estimated systolic pulmonary artery pressure >35 mm Hg) and with versus without RVD (tricuspid annular plane systolic excursion <17 mm or S wave <9.5 cm/s). The primary endpoint was in-hospital death or ICU admission. A total of 200 patients were included in the final analysis (median age 62 (IQR 52-74) years, 65.5% men). The prevalence of PH and RVD was 12.0% (24/200) and 14.5% (29/200), respectively. Patients with PH were older and had a higher burden of pre-existing cardiac comorbidities and signs of more severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (radiological lung involvement, laboratory findings and oxygenation status) compared with those without PH. Conversely, patients with RVD had a higher burden of pre-existing cardiac comorbidities but no evidence of more severe SARS-CoV-2 infection compared with those without RVD. The presence of PH was associated with a higher rate of in-hospital death or ICU admission (41.7 vs 8.5%, p<0.001), while the presence of RVD was not (17.2 vs 11.7%, p=0.404). Among hospitalised non-ICU patients with COVID-19, PH (and not RVD) was associated with signs of more severe COVID-19 and with worse in-hospital clinical outcome. NCT04318366.

Identifiants

pubmed: 32675217
pii: heartjnl-2020-317355
doi: 10.1136/heartjnl-2020-317355
pmc: PMC7476272
doi:

Banques de données

ClinicalTrials.gov
['NCT04318366']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1324-1331

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Crit Care Med. 2001 Aug;29(8):1551-5
pubmed: 11505125
Chest. 2007 Aug;132(2):410-7
pubmed: 17573487
N Engl J Med. 1977 Mar 3;296(9):476-80
pubmed: 834225
Intensive Care Med. 1998 Oct;24(10):1018-28
pubmed: 9840234
Intensive Care Med. 2006 Jun;32(6):852-7
pubmed: 16614811
Eur Respir J. 2003 Apr;21(4):720-7
pubmed: 12762363
Braz J Med Biol Res. 2014 Oct;47(10):904-10
pubmed: 25118626
Int J Cardiol. 2020 Jul 15;311:116-121
pubmed: 32291207
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Crit Care Resusc. 2020 Apr 01;22(2):91-94
pubmed: 32227819
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Crit Care Resusc. 2020 Apr 15;22(2):95-97
pubmed: 32294809
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Curr Opin Crit Care. 2003 Feb;9(1):15-21
pubmed: 12548024
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Physiol Rev. 2012 Jan;92(1):367-520
pubmed: 22298659
Anesthesiology. 1990 Jun;72(6):966-70
pubmed: 2190501
Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JACC Cardiovasc Imaging. 2020 Apr 28;:
pubmed: 32654963
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Pulm Circ. 2018 Jan-Mar;8(1):2045893217753415
pubmed: 29283029
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
J Am Soc Echocardiogr. 2013 Jan;26(1):1-14
pubmed: 23140849

Auteurs

Matteo Pagnesi (M)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy m.pagnesi@gmail.com.

Luca Baldetti (L)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Alessandro Beneduce (A)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Francesco Calvo (F)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Mario Gramegna (M)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Vittorio Pazzanese (V)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Giacomo Ingallina (G)

Cardiovascular Imaging Unit, San Raffaele Scientific Institute, Milan, Italy.

Antonio Napolano (A)

Cardiovascular Imaging Unit, San Raffaele Scientific Institute, Milan, Italy.

Renato Finazzi (R)

Department of General Medicine and Advanced Care, San Raffaele Scientific Institute, Milan, Italy.

Annalisa Ruggeri (A)

Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.

Silvia Ajello (S)

Cardio-Thoracic Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Giulio Melisurgo (G)

Cardio-Thoracic Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Paolo Guido Camici (PG)

Vita-Salute San Raffaele University, Milan, Italy.

Paolo Scarpellini (P)

Department of Infectious Disease, San Raffaele Scientific Institute, Milan, Italy.

Moreno Tresoldi (M)

Department of General Medicine and Advanced Care, San Raffaele Scientific Institute, Milan, Italy.

Giovanni Landoni (G)

Vita-Salute San Raffaele University, Milan, Italy.
Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy.

Fabio Ciceri (F)

Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Anna Mara Scandroglio (AM)

Cardio-Thoracic Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.
Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy.

Eustachio Agricola (E)

Cardiovascular Imaging Unit, San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Alberto Maria Cappelletti (AM)

Cardiac Intensive Care Unit, San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH